CAP Member David A. Schwartz, MD, MS Hyg, FRSM, FCAP, co-editor of the Springer Nature book Pregnant in the Time of Ebola, shares insights on common Ebola questions.
What is Ebola, and why is it taken so seriously?
Ebola is a rare but severe viral infection that can quickly become life-threatening. It’s endemic in certain regions of Africa, and while outbreaks are typically limited to those areas, the seriousness of the illness means each case is treated as a public health priority.
How is Ebola diagnosed?
Ebola is confirmed through laboratory testing, most commonly using PCR, which detects the genetic material of the virus in a patient’s blood or other body fluids. PCR is a highly sensitive test that acts like a molecular copy machine, amplifying tiny amounts of viral material so it can be detected. This allows pathologists to confirm infection with a high degree of accuracy, even when the virus is present at very low levels. PCR gives us a way to find the virus early and with precision. It’s how pathologists turn a suspected case into a confirmed diagnosis.
What makes Ebola difficult to diagnose early?
The early symptoms of Ebola, including fever, malaise, sore throat, headache, and muscle aches, are not specific and can resemble other infections—such as malaria, meningitis, typhoid fever and other viral hemorrhagic fevers—that are common in the endemic regions. The virus also may not be detectable in the blood immediately after symptoms begin, which can complicate early testing. That overlap is what makes early diagnosis challenging, because it can look like many other infections at first.
How long after exposure do symptoms appear?
Symptoms of Ebola can appear anywhere from 2 to 21 days after exposure. People aren’t considered contagious during this incubation period; they only become infectious once symptoms begin. This timeline helps public health teams determine how long individuals should be monitored after a potential exposure.
Why are people without symptoms monitored for 21 days?
The 21-day monitoring period reflects the longest known incubation window for Ebola. Monitoring during this time is designed to identify symptoms as early as possible and prevent potential spread. This monitoring period is about caution, not alarm. It allows public health teams to stay ahead of the virus and respond quickly if symptoms develop.
How does Ebola spread?
Ebola spreads through direct contact with blood or body fluids (such as saliva, sweat, vomit, feces, semen, or breast milk) from someone who is infected. It can also be spread through contact with contaminated surfaces and objects (needles, clothing, bedding, and medical equipment). Ebola does not spread through the air. It requires direct contact with infected materials, which is an important distinction. In the endemic regions, it’s often transmitted from funerary practices, and can also be acquired from contact with an infected animal.
Is Ebola an airborne virus?
No. Ebola is not airborne. Unlike respiratory viruses, it doesn’t spread through droplets or aerosols in the air, and people cannot contract it simply by being near someone who is infected.
How contagious is Ebola?
Ebola is not easily spread in casual settings. Transmission requires close, direct exposure, which is why cases are most often seen among caregivers, family members, and health care workers who don’t have appropriate protective equipment. This is not a virus that spreads casually. It takes close contact—which also means there are clear ways to prevent it.
When is someone contagious?
Individuals with Ebola become contagious once they begin to show symptoms, which helps focus on identifying and isolating cases quickly. They aren’t considered contagious before symptom onset, which helps guide monitoring and containment strategies. After a person dies from Ebola virus infection, their body fluids remain infectious.
How serious is Ebola infection?
Ebola can be a severe illness, with some outbreaks associated with high mortality. It’s especially dangerous when it occurs during pregnancy. However, outcomes vary depending on the strain and access to care, and early supportive treatment can make a real difference.
Is there a treatment or vaccine for Ebola?
There are vaccines and targeted treatments available for some types of Ebola, specifically the Zaire ebolavirus species. Unfortunately, currently used antiviral medications, monoclonal antibody therapies, and vaccines are not effective against the Bundibugyo ebolavirus, which is what’s causing the current Ituri Province outbreak in DR Congo. Supportive care, including hydration and symptom management, remains a cornerstone of treatment and can significantly improve outcomes.
Can Ebola be transmitted after someone recovers?
In rare cases, the virus can persist in certain parts of the body, such as in semen, for months after recovery. This has led to occasional cases of delayed transmission. It can also remain in the ocular tissues in a small number of people who have recovered. These are uncommon cases, but it’s one reason why follow-up guidance is important.
Could Ebola spread widely like COVID-19?
Ebola behaves very differently from COVID-19. Because it requires direct contact with infected body fluids rather than spreading through the air, it’s far less likely to spread widely across communities in the same way. Ebola is more severe in how it affects the body, but much less efficient at spreading, especially compared to airborne viruses.
What is the risk to the United States?
The risk to the United States remains low because we have strong systems in place to detect and contain cases. Layered public health strategies, surveillance systems, contact tracing, infection prevention protocols, digital data management, and laboratory capacity all support early detection and containment of potential cases.
Should travelers be concerned?
For most travelers, the risk is low. Awareness is important for those traveling to areas with active outbreaks, but Ebola does not spread through routine travel interactions. For most people, this is not something that should change travel plans. Risk is tied to specific exposures, not casual travel.
Who is most at risk for Ebola?
Those at highest risk include health care workers, caregivers, and individuals with direct exposure to infected body fluids. The general public is not considered at high risk.
What role do pathologists play in Ebola response?
Pathologists play a central role in diagnosing Ebola and ensuring that suspected cases are accurately confirmed. Their work helps distinguish Ebola from other illnesses with similar symptoms and informs both patient care and public health response. Pathologists have been highly involved in delineating the mechanisms of disease among infected persons, and in identifying the effects of the virus during pregnancy and how it’s transmitted from a pregnant woman to her fetus. Pathologists are the ones who provide the answers behind the scenes. Laboratory confirmation is what allows clinicians and public health teams to act quickly and with confidence.